A new study highlights the feasible use of mhealth devices to help with the...
A new study highlights the feasible use of mhealth devices to help with the screening and detection of atrial fibrillation.
Source: Huawei Telecommunications

Using mhealth for detecting atrial fibrillation

A new study, presented at the European Society of Cardiology (ESC) annual congress, highlights the feasible use of mobile health (mhealth) devices to help with the screening and detection of atrial fibrillation (AF), a common heart condition.

Atrial fibrillation is a heart rhythm condition that causes an irregular and sometimes, abnormally fast heart rate. In AF, the heart’s upper chambers (atria) contract randomly and sometimes so fast that the heart muscle cannot relax properly between contractions. This reduces the heart’s efficiency and performance – but also leads to a higher risk of blood clots. AF is the most common heart rhythm disturbance, affecting around one million people in the UK. People with AF are at increased risk of having a stroke and dying, as well as heart failure and dementia. Currently, low detection due to lack of visible symptoms and nonadherence are major problems in current management approaches for patients with suspected AF.

Photoplethysmography technology

mhealth devices, such as fitness trackers, smart watches and mobile phones, may enable earlier AF detection, and improved AF management through the use of photoplethysmography (PPG) technology. PPG is a simple and low-cost optical technique that can be used to detect blood volume changes in the microvascular bed of tissue. It is often used non-invasively to make measurements at the skin surface.

Researchers, led by Associate Professor Guo from Chinese PLA General Hospital in Beijing, and Professor Gregory Lip, Lead for the Liverpool Centre for Cardiovascular Science/Price-Evans Chair of Cardiovascular Medicine at University of Liverpool, aimed to determine the feasibility of AF screening in a large population-based cohort using smart devices with PPG technology, combined with a clinical care AF management pathway. As part of the study AF screening was performed with smart wristbands (HONOR BAND 4) or watches (HUAWEI WATCH GT, HONOR WATCH)** using PPG technology (Huawei Technologies Co., Ltd., Shenzhen, China)*** made available for the population aged over 18 years across China for approximately seven months (October 26, 2018 to May 20, 2019).

Overall 187,912 participants used smart devices to monitor their pulse rhythm. During this time 424 (0.23%) of the individuals received a ‘suspected AF’ notification. Of those 227 (87%) were confirmed as having AF by health providers and other secondary examinations. These patients were provided with therapy and successfully anticoagulated.

Associate Professor Guo, said: “Based on our present study, continuous home-monitoring with smart device based PPG technology could be a feasible, cost-effective approach for AF screening. There were 95% patients following entry into a programme of integrated AF care, and approximately 80% of high risk patients were successfully anticoagulated. This would help efforts at screening and detection of AF, as well as early interventions to reduce stroke and other AF-related complications.”

Professor Lip, said: “Improved AF care requires early detection and the opportunity for streamlined management decision-making. Better detection can be followed by implementing the priorities of AF management, which is as ‘easy as ABC’: Avoid stroke; Better symptom optimisation; Cardiovascular and risk factor management.”

Subscribe to our newsletter

Related articles

Wearable sensor tracks biochemical data

Wearable sensor tracks biochemical data

Scientist are developing a patch that monitors the sweat of high performance athletes for medical information.

Necklace detects abnormal heart rhythm

Necklace detects abnormal heart rhythm

A necklace which detects abnormal heart rhythm will be showcased for the first time on EHRA Essentials 4 You, a scientific platform of the European Society of Cardiology (ESC).

Activity trackers help manage diabetes

Activity trackers help manage diabetes

Patients with diabetes and cardiovascular disease who used wearable step-counting devices have shown small-to-medium improvements in physical activity.

mhealth: health studies to benefit from Apple watch

mhealth: health studies to benefit from Apple watch

During its latest keynote presentation, tech giant Apple announced cooperations for health studies. The latest model of their smartwatches are to be key in their execution.

Update Apple Heart Study: Wearables can detect aFib

Update Apple Heart Study: Wearables can detect aFib

The clinical trial to determine whether a smartwatch app that analyzes pulse-rate data can screen for a heart-rhythm disorder has enrolled more than 400,000 participants.

Smartwatch detects atrial fibrillation faster

Smartwatch detects atrial fibrillation faster

Atrial fibrillation can be correctly detected using commercially available smartwatches and thus reduce the risk for a stroke significantly.

Smart wristband monitors heart rates and physical activity

Smart wristband monitors heart rates and physical activity

Engineers have created biosensor technology with a wireless connection to smartphones that will enable a new wave of personal health.

Medical technology 2020 – a review

Medical technology 2020 – a review

Covid-19 gave many of these predictions for 2020 an entirely new spin: while some of the hyped trends turned out to play only bit-parts others became box-office hits in the new normal.

Earable computing: A new research area in the making

Earable computing: A new research area in the making

CSL's Systems and Networking Research Group (SyNRG) is defining a new sub-area of mobile technology that they call "earable computing."

Popular articles